Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database

As ibrutinib has become a standard of care in B-cell malignancies in monotherapy or in combination with other agents, definition of its safety profile appears essential. The aim of this study was to further characterize the safety profile of ibrutinib through the identification of potential safety s...

Descripción completa

Detalles Bibliográficos
Autores principales: Allouchery, Marion, Tomowiak, Cécile, Lombard, Thomas, Pérault-Pochat, Marie-Christine, Salvo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580940/
https://www.ncbi.nlm.nih.gov/pubmed/34776981
http://dx.doi.org/10.3389/fphar.2021.769315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580940/
https://www.ncbi.nlm.nih.gov/pubmed/34776981
http://dx.doi.org/10.3389/fphar.2021.769315

Ejemplares similares